Amorphis Pharma Development Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Amorphis Pharma Development General Information

Description

Developer of amorphous drugs designed to have increased effectiveness as compared to drugs in oral solid forms. The company specializes in the amorphization and stabilization of pharmaceutically active substances to create drugs from the added-value medicines segment, that have good characteristics compared to the originals, enabling healthcare providers to improve the comfort of therapy rendered to patients by administering drugs in a stable amorphous form.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Bankowa 12 lok 147
  • Katowice, 40-007
  • Poland
+48 608
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Bankowa 12 lok 147
  • Katowice, 40-007
  • Poland
+48 608

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amorphis Pharma Development Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 02-Mar-2023 Completed Generating Revenue
1. Seed Round 01-Jan-2019 Completed Startup
To view Amorphis Pharma Development’s complete valuation and funding history, request access »

Amorphis Pharma Development Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of amorphous drugs designed to have increased effectiveness as compared to drugs in oral solid forms. The comp
Drug Discovery
Katowice, Poland

North Brunswick, NJ
 

Lawrenceville, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Amorphis Pharma Development Competitors (3)

One of Amorphis Pharma Development’s 3 competitors is Ascendia Pharmaceuticals, a Private Equity-Backed company based in North Brunswick, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ascendia Pharmaceuticals Private Equity-Backed North Brunswick, NJ
Adare Pharma Solutions Private Equity-Backed Lawrenceville, NJ
Lonza Group Corporation Basel, Switzerland
You’re viewing 3 of 3 competitors. Get the full list »

Amorphis Pharma Development Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
StartSmart CEE Accelerator/Incubator
INNOventure (Poland) Venture Capital Minority
To view Amorphis Pharma Development’s complete investors history, request access »

Amorphis Pharma Development FAQs

  • When was Amorphis Pharma Development founded?

    Amorphis Pharma Development was founded in 2018.

  • Where is Amorphis Pharma Development headquartered?

    Amorphis Pharma Development is headquartered in Katowice, Poland.

  • What industry is Amorphis Pharma Development in?

    Amorphis Pharma Development’s primary industry is Drug Discovery.

  • Is Amorphis Pharma Development a private or public company?

    Amorphis Pharma Development is a Private company.

  • What is Amorphis Pharma Development’s current revenue?

    The current revenue for Amorphis Pharma Development is .

  • How much funding has Amorphis Pharma Development raised over time?

    Amorphis Pharma Development has raised $265K.

  • Who are Amorphis Pharma Development’s investors?

    StartSmart CEE and INNOventure (Poland) have invested in Amorphis Pharma Development.

  • Who are Amorphis Pharma Development’s competitors?

    Ascendia Pharmaceuticals, Adare Pharma Solutions, and Lonza Group are competitors of Amorphis Pharma Development.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »